Coccidioidomycosis in Oklahoma: A retrospective case series

Abstract

AbstractBackgroundCoccidioidomycosis is a systemic fungal disease endemic to arid regions of the Western Hemisphere. In the south‐western US, Coccidioides spp. may account for up to 20%–25% of all cases of community acquired pneumonia. Clinical manifestations vary widely, from asymptomatic infection to life‐threatening disease, especially in immunocompromised hosts.ObjectivesThe primary objective of the study was to characterise cases of coccidioidomycosis in an area of the United States not considered traditionally endemic for the disease.MethodsWe performed a single‐centre retrospective study of all cases of coccidioidomycosis from 1 January 2000 to 31 December 2020, in the University of Oklahoma Health Sciences Medical Center.ResultsA total of 26 patients were included for analysis. The central nervous system (CNS) and the lungs were the sites most frequently involved. Twenty (77%) had travelled to a coccidioidomycosis endemic region. Most were male (81%) with a median age of 42 years (range: 3–78 years). The majority (46%) were Caucasians, 19% were African American, 19% Hispanic, and 12% Native American. The most common comorbidities were diabetes mellitus and acquired immunodeficiency syndrome, identified in 27% and 23% of patients, respectively. Patients on immunosuppressive therapy accounted for 12% of all cases.ConclusionOur study is one of the largest single‐centre case series of coccidioidomycosis from a non‐endemic area. Diabetes mellitus was the most frequent comorbidity. Compared to other case series of coccidioidomycosis, our patient population had higher rates of immunosuppression and had both a higher rate of disseminated disease and overall mortality.